HIF2α induces cardiomyogenesis via Wnt-β-catenin signaling in mouse embryonic stem cellsReportar como inadecuado

HIF2α induces cardiomyogenesis via Wnt-β-catenin signaling in mouse embryonic stem cells - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Journal of Translational Medicine

, 13:88

First Online: 14 March 2015Received: 04 November 2014Accepted: 27 February 2015DOI: 10.1186-s12967-015-0447-7

Cite this article as: Sun, X., Pang, L., Shi, M. et al. J Transl Med 2015 13: 88. doi:10.1186-s12967-015-0447-7


BackgroundEmbryonic stem cells ESCs are pluripotent stem cells and can differentiate into cardiomyocytes when cultured in appropriate conditions. The function of hypoxia-inducible factors HIFs has been identified in directing the formation of cardiac lineages. The purpose of this study was to investigate the ability of HIF2α to induce differentiation of ESCs into cardiomyocytes and to explore the potential underlying molecular mechanisms.

MethodsCardiac differentiation from mouse ESCs was analyzed using the -hanging drop- method, and success was determined by assaying the numbers of beating embryoid bodies and the expression level of cardiac markers. The expression of HIF2α was then manipulated during cardiac differentiation with piggyBac transposon and the lentivirus system. The underlying mechanism was finally examined via administering selective inhibitors of the Wnt-β-catenin signaling pathway.

ResultsOverexpressing HIF2α can significantly drive mouse ESCs to form cardiomyocytes. Contrarily, knockdown of HIF2α inhibits the emergence of cardiac cells. In addition, the cardiomyogenesis-promoting effect of HIF2α occurred by increasing the protein level of β-catenin, an effector that contributes to cardiac differentiation at an early stage of ESC differentiation.

ConclusionHIF2α has a cardiomyogenesis-promoting effect in ESCs via enhancing the activation of the Wnt-β-catenin signaling pathway. Our results may be beneficial for generating and applying cardiomyocytes from ESCs safely and effectively in the future.

KeywordsEmbryonic stem cells Cardiomyogenesis HIF2α β-catenin AbbreviationsESCsEmbryonic stem cells

HIFHypoxia-inducible factor

shRNAshort-hairpin RNA

EBsEmbryoid bodies

NTNo treatment

Electronic supplementary materialThe online version of this article doi:10.1186-s12967-015-0447-7 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Xiaotian Sun - Liewen Pang - Meng Shi - Jiechun Huang - Yiqing Wang

Fuente: https://link.springer.com/

Documentos relacionados